IFNG and B-cell chronic lymphocytic leukemia: Functionality was demonstrated by immune synapse assay, multiparametric intracellular flow cytometry, IFN-γ ELISpot, 51Cr release, and suppression of CLL disease in a humanized in vivo mouse model.